Nasopharyngeal carcinoma: a model cancer to understand tumor rejection

Bibliographic Details
Published in:	Signal Transduction and Targeted Therapy
Main Authors:	Gerard J. Nuovo, Esmerina Tili, Carlo M. Croce
Format:	Article
Language:	English
Published:	Nature Publishing Group 2025-06-01
Online Access:	https://doi.org/10.1038/s41392-025-02273-0

Similar Items

SARS-CoV-2 spike protein-induced inflammation underlies proarrhythmia in COVID-19
by: Louisa Mezache, et al.
Published: (2025-09-01)

Resveratrol, MicroRNAs, Inflammation, and Cancer
by: Esmerina Tili, et al.
Published: (2011-01-01)

Multimodality radiomics for tumor prognosis in nasopharyngeal carcinoma.
by: Sararas Khongwirotphan, et al.
Published: (2024-01-01)

Multimodality radiomics for tumor prognosis in nasopharyngeal carcinoma
by: Sararas Khongwirotphan, et al.
Published: (2024-01-01)

Nasopharyngeal Carcinoma
by: Pedro Juan Barrios Fuentes
Published: (2019-04-01)

Nasopharyngeal carcinoma
by: Brennan Bernadette
Published: (2006-06-01)

Familial clustering of nasopharyngeal carcinoma in the family of an adolescent with nasopharyngeal carcinoma
by: Buket Kara, et al.
Published: (2022-12-01)

Nasopharyngeal carcinoma in a 15-year-old: A rare pediatric tumor
by: Safina Zahir Msangi, MD, et al.
Published: (2025-09-01)

PXDN as a pan-cancer biomarker and promotes tumor progress via immune inhibition in nasopharyngeal carcinoma
by: Yu-Chun Li, et al.
Published: (2024-09-01)

Neoadjuvant Chemotherapy in Nasopharyngeal Carcinoma
by: Khudair J. Sabeeh Al-Rawaq
Published: (2012-04-01)

Tumor Lysis Syndrome Due to Pembrolizumab Use in Metastatic Nasopharyngeal Carcinoma
by: Aykut Turhan, et al.
Published: (2024-01-01)

Circulating tumor DNA laboratory processes and clinical applications in nasopharyngeal carcinoma
by: Ziman Wu, et al.
Published: (2025-05-01)

Baseline SUVmax is correlated with tumor hypoxia and patient outcomes in nasopharyngeal carcinoma
by: Jianming Ding, et al.
Published: (2024-08-01)

Revealing the crosstalk between nasopharyngeal carcinoma and immune cells in the tumor microenvironment
by: Jianyun Jiang, et al.
Published: (2022-08-01)

Protocadherin 17 Is a Tumor Suppressor and Is Frequently Methylated in Nasopharyngeal Carcinoma [Retraction]
by: He Y, et al.
Published: (2020-05-01)

Against a Metaphysical Understanding of Rejection
by: Mariela Rubin, et al.
Published: (2018-08-01)

EBV based cancer prevention and therapy in nasopharyngeal carcinoma
by: Ya Cao
Published: (2017-05-01)

Nasopharyngeal carcinoma: Imaging features of unusual cancer in children
by: Ayda A. Youssef, et al.
Published: (2015-12-01)

T Cell Therapy for Nasopharyngeal Carcinoma
by: S Basso, M Zecca, P Merli, A Gurrado, S Secondino, G Quartuccio, I Guido, P Guerini, G Ottonello, N Zavras, R Maccario, P Pedrazzoli, P Comoli
Published: (2011-01-01)

A tumor microenvironment-associated circRNA predictor for tumor relapse and chemotherapy vulnerability in nasopharyngeal carcinoma
by: Ye-Lin Liang, et al.
Published: (2023-12-01)

NSUN2 Promotes Tumor Progression and Regulates Immune Infiltration in Nasopharyngeal Carcinoma
by: Xinya Tong, et al.
Published: (2022-04-01)

Nasopharyngeal Carcinoma During Pregnancy
by: Tsung-I Lin, et al.
Published: (2007-12-01)

Advancements in the epidemiology of nasopharyngeal carcinoma
by: DU Yun, et al.
Published: (2024-09-01)

Re-searching nasopharyngeal carcinoma
by: Ingemar Ernberg, et al.
Published: (2024-09-01)

Hypercalcemia due to Nasopharyngeal Carcinoma
by: Shipra Chaudhary, et al.
Published: (2017-03-01)

EGFR Mutation in Nasopharyngeal Carcinoma
by: Evren Uzun, et al.
Published: (2022-10-01)

The Role of PTEN in Nasopharyngeal Carcinoma
by: Yan Chen, et al.
Published: (2024-05-01)

Precision radiotherapy for nasopharyngeal carcinoma
by: Zhenyu Zhang, et al.
Published: (2024-03-01)

Advanced nasopharyngeal carcinoma in children
by: Wan-Chen Kao, et al.
Published: (2016-09-01)

Prognostic models for early and late tumor progression prediction in nasopharyngeal carcinoma: An analysis of 8292 endemic cases
by: Lu‐Lu Zhang, et al.
Published: (2023-03-01)

Circulating tumor cells with karyotyping as a novel biomarker for diagnosis and treatment of nasopharyngeal carcinoma
by: Jing Zhang, et al.
Published: (2018-11-01)

Nasopharyngeal Carcinoma Cell Lines: Reliable Alternatives to Primary Nasopharyngeal Cells?
by: Anna Makowska, et al.
Published: (2024-03-01)

Metastatic nasopharyngeal carcinoma: Outcome from Cancer Institute, Chennai
by: Arun Kumar, et al.
Published: (2020-01-01)

Challenges in diagnosing nasopharyngeal tumors
by: Alexandru Aristide Alexe, et al.
Published: (2024-10-01)

Use of camrelizumab in treatment of nasopharyngeal carcinoma
by: Yu. V. Alymov, et al.
Published: (2024-12-01)

Establishment of a Zebrafish Xenograft Model for Investigation of Nasopharyngeal Carcinoma
by: Enyu Huang, et al.
Published: (2022-09-01)

Ropivacaine-loaded tumor-derived vesicles targeting CCNB1 and autophagy in nasopharyngeal carcinoma
by: Xue Zhang, et al.
Published: (2025-10-01)

The key role of DLX6 in nasopharyngeal carcinoma: metastasis, angiogenesis and tumor immune mechanism
by: Hanxuan Yang, et al.
Published: (2025-03-01)

Nasopharyngeal Carcinoma Subtype Discovery via Immune Cell Scores from Tumor Microenvironment
by: Yanbo Sun, et al.
Published: (2023-01-01)

HMGA2 promotes nasopharyngeal carcinoma progression and is associated with tumor resistance and poor prognosis
by: Xinting Ouyang, et al.
Published: (2024-01-01)